Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis.
Hiroki TanahashiKakuhiro YamaguchiKoji KuroseSatoshi NakaoShinjiro SakamotoYasushi HorimasuTakeshi MasudaShintaro MiyamotoTaku NakashimaHiroshi IwamotoKazunori FujitakaHironobu HamadaToru OgaMikio OkaNoboru HattoriPublished in: Respirology (Carlton, Vic.) (2022)
Our results suggest that HMGB1 may be a potential blood marker to predict the development and severity of CIP in NSCLC patients.